Cases & Deals

Celgene seeks patent protection for different oral formulations of 5-AZACYTIDINE

Clients Celgene Corporation

Jones Day is prosecuting applications and developing a patent portfolio on behalf of Celgene Corporation for oral formulations of 5-AZACYTIDINE.